A new report highlights a disturbing increase in HPV-related cancers among some women in the U.S., despite the availability of an effective vaccine and screening methods. Cervical cancer, largely caused by HPV, is highly preventable with the HPV vaccine and regular Pap tests. However, researchers suggest that a combination of factors, including reduced screening rates in specific populations and unequal access to healthcare, are hindering progress.
Specifically, the study points to disparities in screening uptake based on factors like socioeconomic status and geographic location. Women in rural areas or with limited access to healthcare facilities may face significant barriers to getting screened. The report emphasizes the importance of public health initiatives aimed at improving access to HPV vaccination and cervical cancer screening programs, particularly for underserved communities. Healthcare providers are urged to educate patients about the benefits of vaccination and routine screenings to reverse this worrying trend and protect women's health.
Experts recommend that girls and boys receive the HPV vaccine starting at age 11 or 12. Regular Pap tests are recommended for women starting at age 21 to detect precancerous changes early. If detected early, cervical cancer is highly treatable, underscoring the importance of proactive preventative care.
HPV-Related Cancers Increasing in Some U.S. Women
While the HPV vaccine offers strong protection against cervical cancer, a recent study indicates a concerning trend: HPV-related cancers are on the rise in certain groups of women in the United States. Experts believe that declining screening rates and disparities in access to care may be contributing factors. Early detection remains crucial for successful treatment, making regular check-ups essential.
Source: Read the original article at NBC